MENU
+Compare
VSBC
Stock ticker: OTC
AS OF
Nov 13 closing price
Price
$1.00
Change
-$0.00 (-0.00%)
Capitalization
3.1B

VSBC VitaSpring Biomedical Co. Ltd. Forecast, Technical & Fundamental Analysis

VitaSpring Biomedical Co Ltd is a start-up business company... Show more

VSBC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for VSBC with price predictions
Nov 12, 2025

VSBC sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for VSBC moved above the 200-day moving average on November 10, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VSBC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: VSBC's P/B Ratio (2000.000) is very high in comparison to the industry average of (24.439). VSBC's P/E Ratio (3305.421) is considerably higher than the industry average of (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (666.667) is also within normal values, averaging (322.723).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VSBC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
VSBC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
400 Spectrum Center Dr. No. 1620
Phone
+1 949 202-9235
Employees
N/A
Web
https://www.vitaspringbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTVAX31.72-0.07
-0.22%
FullerThaler Behav Md-Cp Val A
CSHCX8.29-0.06
-0.72%
NYLI Cushing® MLP Premier Class C
RGBFX41.82-0.38
-0.90%
American Funds Global Balanced R5
JVTNX89.82-2.02
-2.20%
Janus Henderson Venture N
AGCVX20.03-0.45
-2.20%
American Century Global Small Cap Inv